Reduction of NRI and phosphorylated Ca2+/calmodulin-dependent protein kinase II levels in Alzheimer's disease

NeuroReport

Volumn 16, Issue 16, 2005, Pages 1809-1813

  Amada, Naoki ^a   Aihara, Koutoku ^a   Ravid, Rivka ^b   Horie, Masato ^a  

^a OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^b NETHERLANDS BRAIN BANK   (Netherlands)

Author keywords

Alzheimer's disease; Ca2+ calmodulin dependent protein kinase II; Frontal cortex; Hippocampus; N methyl D aspartate receptor

Indexed keywords

CALCIUM ION; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; PROTEIN KINASE (CALCIUM,CALMODULIN) II; CALMODULIN DEPENDENT PROTEIN KINASE II; CALMODULIN-DEPENDENT PROTEIN KINASE II; FLAVOPROTEIN; NDOR1 PROTEIN, HUMAN; OXIDOREDUCTASE; PROTEIN KINASE (CALCIUM,CALMODULIN);

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN LEVEL; CALCIUM TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME PHOSPHORYLATION; FEMALE; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; TISSUE DISTRIBUTION; CADAVER; COMPARATIVE STUDY; ENZYMOLOGY; GENE EXPRESSION REGULATION; METABOLISM; METHODOLOGY; MIDDLE AGED; PHOSPHORYLATION; PHYSIOLOGY; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BLOTTING, WESTERN; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; FEMALE; FLAVOPROTEINS; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; OXIDOREDUCTASES; PHOSPHORYLATION; POSTMORTEM CHANGES;

EID: 27544451159     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wnr.0000185015.44563.5d     Document Type: Article

References (25)

1. Bliss TV, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993; 361:31-39.
2. Malenka RC, Nicoll RA. Long-term potentiation: a decade of progress? Science 1999; 285:1870-1874.
3. 2+/calmodulin-dependent protein kinase II. J Biol Chem 2001; 276:3719-3722.
4. Cullen WK, Suh YH, Anwyl R, Rowan MJ. Block of LTP in rat hippocampus in vivo by beta-amyloid precursor protein fragments. Neuroreport 1997; 8:3213-3217.
5. Itoh A, Akaike T, Sokabe M, Nitta A, Iida R, Olariu A, et al. Impairments of long-term potentiation in hippocampal slices of beta-amyloid-infused rats. Eur J Pharmacol 1999; 382:167-175.
6. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 2002; 416:535-539.
7. Trinchese F, Liu S, Battaglia F, Walter S, Mathews PM, Arancio O. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice. Ann Neurol 2004; 55:801-814.
8. Sze C, Bi H, Kleinschmidt-DeMasters BK, Filley CM, Martin LJ. N-methyl-D-aspartate receptor subunit proteins and their phosphorylation status are altered selectively in Alzheimer's disease. J Neurol Sci 2001; 182:151-159.
9. Bi H, Sze CI. N-methyl-D-aspartate receptor subunit NR2A and NR2B messenger RNA levels are altered in the hippocampus and entorhinal cortex in Alzheimer's disease. J Neurol Sci 2002; 200:11-18.
10. Mah VH, Eskin TA, Kazee AM, Lapham L, Higgins GA. In situ hybridization of calcium/calmodulin dependent protein kinase II and tau mRNAs; species differences and relative preservation in Alzheimer's disease. Brain Res Mol Brain Res 1992; 12:85-94.
11. Simonian NA, Elvhage T, Czernik AJ, Greengard P, Hyman BT. Calcium/calmodulin-dependent protein kinase II immunostaining is preserved in Alzheimer's disease hippocampal neurons. Brain Res 1994; 657:294-299.
12. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944.
13. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41:479-486.
14. Braak H, Braak E. Evolution of the neuropathology of Alzheimer's disease. Acta Neurol Scand Suppl 1996; 165:3-12.
15. Aihara K, Kuroda S, Kanayama N, Matsuyama S, Tanizawa K, Horie M. A neuron-specific EGF family protein, NELL2, promotes survival of neurons through mitogen-activated protein kinases. Brain Res Mol Brain Res 2003; 116:86-93.
16. Hollmann M, Heinemann S. Cloned glutamate receptors. Annu Rev Neurosci 1994; 17:31-108.
17. Gao XM, Sakai K, Roberts RC, Conley RR, Dean B, Tamminga CA. Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. Am J Psychiatry 2000; 157:1141-1149.
18. Meyer T, Hanson PI, Stryer L, Schulman H. Calmodulin trapping by calcium-calmodulin-dependent protein kinase. Science 1992; 256: 1199-1202.
19. De Koninck P, Schulman H. Sensitivity of CaM kinase II to the frequency of Ca2+ oscillations. Science 1998; 279:227-230.
20. Leonard AS, Lim IA, Hemsworth DE, Horne MC, Hell JW. Calcium/calmodulin- dependent protein kinase II is associated with the N-methyl-D-aspartate receptor. Proc Natl Acad Sci USA 1999; 96:3239-3244.
21. Barria A, Muller D, Derkach V, Griffith LC, Soderling TR. Regulatory phosphorylarion of AMPA-type glutamate receptors by CaM-KII during long-term potentiation. Science 1997; 276:2042-2045.
22. Giese KP, Fedorov NB, Filipkowski RK, Silva AJ. Autophosphorylation at Thr286 of the alpha calcium-calmodulin kinase II in LTP and learning. Science 1998; 279:870-873.
23. Tsien JZ, Huerta PT, Tonegawa S. The essential role of hippocampal CA1 NMDA receptor-dependent synapttc plasticity in spatial memory. Cell 1996; 87:1327-1338.
24. Grady CL, Furey ML, Pietrini P, Horwitz B, Rapoport SI. Altered brain functional connectivity and impaired short-term memory in Alzheimer's disease. Brain 2001; 124(Pt 4):739-756.
25. Leonard AS, Bayer KU, Merrill MA, Lim IA, Shea MA, Schulman H, et al. Regulation of calcium/calmodulin-dependent protein kinase II docking to N-methyl-D-aspartate receptors by calcium/calmodulin and alpha-actinin. J Biol Chem 2002; 277:48441-48448.